Overview

Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The primary objective is to study the efficacy of piperacillin/tazobactam in patients with complicated urinary tract infections
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Penicillanic Acid
Piperacillin
Piperacillin, Tazobactam Drug Combination
Tazobactam